Abstract
Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Current Genomics
Title: Bioengineered Crops: The Commercial and Ethical Considerations
Volume: 2 Issue: 2
Author(s): Susmita Sengupta, L. K. Sengupta and P. S. Bisen
Affiliation:
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Abstract: Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Export Options
About this article
Cite this article as:
Sengupta Susmita, Sengupta K. L. and Bisen S. P., Bioengineered Crops: The Commercial and Ethical Considerations, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013351011
DOI https://dx.doi.org/10.2174/1389202013351011 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Mitochondrial Lipids as Apoptosis Regulators
Current Medicinal Chemistry PET/CT Dose Planning for Volumetric Modulated arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients
Current Radiopharmaceuticals ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry Dendritic Cells: More Than Just Adaptive Immunity Inducers?
Current Immunology Reviews (Discontinued) Managing Expectations in the Transition to Proof of Concept Studies
Reviews on Recent Clinical Trials Synthesis, Activity and Binding with DNA of [{trans-PtCl(NH ) }2μ-{trans- Pd(4-hydroxypyridine) (H N(CH ) NH ) ]Cl (TH8)
Medicinal Chemistry Novel and Emerging Drugs for Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities - a Review
Current Pharmaceutical Design Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents A Review on Structures and Functions of Bcl-2 Family Proteins from Homo sapiens
Protein & Peptide Letters Fentanyl for Breakthrough Cancer Pain: Where are We?
Reviews on Recent Clinical Trials Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates
Current Medicinal Chemistry Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Current Cancer Drug Targets Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
Current Topics in Medicinal Chemistry Periodontal Disease and Potential Association with Systemic Diseases and Conditions (Mini-review)
Applied Clinical Research, Clinical Trials and Regulatory Affairs Thiazolides, a Novel Class of Anti-Infective Drugs, Effective Against Viruses, Bacteria, Intracellular and Extracellular Protozoan Parasites and Proliferating Mammalian Cells
Anti-Infective Agents iNOS: A Potential Therapeutic Target for Malignant Glioma
Current Molecular Medicine Anesthetic Pharmacology for Kidney Transplantation
Current Clinical Pharmacology MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets